IN VITRO AND IN VIVO STUDIES OF ANTIHYPERURICEMIC AND ANTIOXIDANT ACTIVITY FROM BULBS OF BAWANG TIWAI (ELEUTHERINE PALMIFOLIA (L.) MERR.) FROM INDONESIA by Laksmitawati, Dian Ratih et al.
Vol 12, Issue 1, 2019
Online - 2455-3891 
Print - 0974-2441
IN VITRO AND IN VIVO STUDIES OF ANTIHYPERURICEMIC AND ANTIOXIDANT ACTIVITY 
FROM BULBS OF BAWANG TIWAI (ELEUTHERINE PALMIFOLIA (L.) MERR.) FROM INDONESIA
DIAN RATIH LAKSMITAWATI*, RININTA FIRDAUS, MEDIANA ASTIKA ZEIN
Department of Pharmacy, Faculty of Pharmacy, University of Pancasila, Srengseng Sawah, Jagakarsa, Jakarta, 12640, Indonesia. 
Email: dianratih.ffup@gmail.com
Received: 31 October 2018, Revised and Accepted: 14 December 2018
ABSTRACT
Objectives: This study would like to investigate the in vitro antioxidant activity through 2,2-diphenyl-1-picrylhydrazyl assay and in vitro xanthine 
oxidase activity of the bulbs. This study performs in vivo assays to study the antihyperuricemic activity and antioxidant in the hyperuricemic rat 
through plasma malondialdehyde measurement.
Method: The study was conducted by testing the fresh bulbs of bawang tiwai (Eleutherine palmifolia (L.) Merr. with chemical solvent of ethanol 70% 
to extract the bulbs. Allopurinol and Vitamin C were used as positive control for the antihyperuricemic assay and antioxidant assay, respectively. Other 
chemical substances were also used in this study. This study used chicken extract (Brands) 20 ml/kg/body weight to induce the level of uric acid in the 
blood serum, and potassium oxonate (Sigma 156124) to inhibit the uricase in rats.
Results: The results show that the levels of uric acid were measured using spectrophotometer with dichloro-hydroxybenzen sulfonate (Biolabo) a as 
reagent. The ethanol extract of bawang tiwai (EBT) (E. palmifolia (L.) Merr) was potential to reduce uric acid level at 140, 280, and 560 mg/kg body 
weight, but possibly without inhibition against xanthine oxydase activity.
Conclusion: All doses of EBT could inhibit lipid peroxidation in hyperuricemic condition caused by high purine diet in 14 days.
Keywords: Antihyperuricemic, Antioxidant activity, Bulbs of bawang tiwai, In vitro, In vivo.
INTRODUCTION
Hyperuricemia is a metabolic disorder in the human body with an excess 
of uric acid in blood plasma. It leads to gouty arthritis, characterized 
by inflammatory joints due to the deposition of the crystals. Although 
the risk of mortality is relatively low, gout affects the patient’s quality 
of life. The metabolic pathway for uric acid involves xanthine oxidase, 
an enzyme that catalyzes the oxidation of xanthine to uric acid. High 
activity of xanthine oxidase induces not only the level of uric acid in 
blood but also side products and free radicals. The accumulation of 
free radicals that overwhelms the capacity of endogenous antioxidant 
potentially gives harmful effects to human body.
Flavonoids, isolated from plants, have been reported as a potential 
inhibitor for xanthine oxidase [1-4]. Morin, kaempferol, isorhamnetin, 
and baicalein have been reported to have inhibitory activity against 
xanthine oxydase in vitro [5]. Other reports show that flavonoids 
(quercetin, morin, myricetin, puerarin, and kaempferol) given at 50 
and 100 mg/kg body weight in 3 days with potassium oxonate as an 
inductor are able to reduce the level of hyperuricemia significantly up 
to 35% [6,7].
Bawang Tiwai, also known as bawang dayak (Eleutherine palmifolia (L.) 
Merr.), is a bulbous plant that numerously grows in Borneo. People in 
Borneo consume the bulbs as an alternative medicine to treat common 
diseases. Unlike other bulbous plants, bawang tiwai has less odor and 
distinct flavor compared to red onion (Allium cepa L.) and garlic (Allium 
sativum L.). Moreover, it holds a stronger red pigment than the red onion. 
Bawang Tiwai contains eleutherin, eleutherol, and isoeleutherin which 
have been reported to show antifungal activity [8,9], wound healing 
activity by stimulating Smad-mediated collagen production [10] and 
α-glucosidase inhibitory [11]. To date, there is no empirical report on 
antioxidant, xanthine oxidase inhibitory and antihyperuricemic activity 
of bawang tiwai bulbous. Therefore, this study would like to investigate 
the in vitro antioxidant activity through 2,2-diphenyl-1-picrylhydrazyl 
(DDPH) assay and in vitro xanthine oxidase activity of the bulbs. Then, 
this study performs in vivo assays to study the antihyperuricemic 




A total of 36 of Sprague Dawley rats with weight 150–250 g were 
obtained from Bogor Agricultural University. They were acclimatized for 
a week in light and temperature-controlled room with 12 h dark-light 
cycle. They were fed with standard rat pellet and water, under strict 
hygienic conditions.
Sample, drug, and other chemical substances
Fresh bulbs of bawang tiwai were obtained directly from Borneo. 
The bulbs were determined by Herbarium Bogoriense of Indonesian 
Science Institute (LIPI) Bogor as E. palmifolia (L.) Merr. The chemical 
solvent used to extract the bulbs was ethanol 70%. Allopurinol and 
Vitamin C were used as positive control for the antihyperuricemic assay 
and antioxidant assay, respectively. Other chemical substances used in 
this study were xanthine oxidase (Sigma 4376), xanthine (Sigma 4002), 
phosphate buffer (pH 7.5), DPPH (1,1-difenil-2-pikrilhidrazil) (Sigma), 
malondialdehyde standard (TEP), thiobarbituric acid (TBA) (Merck), 
ethers, ethylenediaminetetraacetic acid, and trichloroacetic acid (TCA). 
We used chicken extract (Brands) 20 ml/kg/body weight to induce the 
level of uric acid in the blood serum, and potassium oxonate (Sigma 
156124) to inhibit the uricase in rats. The levels of uric acid were 
measured using spectrophotometer with dichloro-hydroxybenzen 
sulfonate (Biolabo) as a reagent.
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Preparation of extract
About 400 g of dried bulbs of bawang tiwai were extracted with ethanol 
70% by maceration process for 24 h. The suspension was filtrated, 
and the precipitate was re-macerated 4 times subsequently. Then, the 
extract was concentrated using rotary evaporator at 50–60°C to obtain 
dense ethanol-extract of bawang tiwai (EBT). The percentage of crude 
extract (relative to dried plant material) obtained was 17.2%.
Phytochemical screening
Phytochemical screening of EBT was performed using Farnsworth 
method. It included the identification of alkaloid, flavonoid, saponin, 
tannin, quinone, steroid/triterpenoid, essential oil, and coumarin.
In vitro assay of xanthine oxidase inhibitory activity [12]
The in vitro assay was performed to investigate xanthine oxidase 
inhibitory activity of EBT. First, the absorbance of xanthine, remain 
from uric acid metabolism, was measured at 265 nm. A half milliliter of 
EBT with concentrations of 100, 200, 300, 400, 500, and 600 ppm was 
added to 1.45 ml of phosphate buffer 50 mM, pH 7.5. Then, each mixture 
was added to 1 ml of 0.3 mM xanthine in phosphate buffer. The tubes 
were incubated at 25°C for 15 min. Then, 0.05 ml of 0.3 U/ml xanthine 
oxidase was added to each tube and incubated for 45 min. The reaction 
was stopped by adding 0.5 ml HCl 1N. The absorbance of each mixture 
was measured using spectrophotometer at 265 nm. Allopurinol, as a 
positive control, was measured with the same procedure. The standard 
curve was made using the absorbance of xanthine with known 
concentrations. The absorbance of the mixture of substrate and enzyme 
was used as “blank,” and the absorbance of substrate was used as 









In vitro DDPH antioxidant assay [13]
As stock, 10 mg sample was dissolved in 10 ml methanol (1000 ppm). 
Then, stock solution was diluted into 10, 20, 30, 40, 50, and 60 ppm. 
Each mixture was added to 1 ml of DPPH 0.4 mM and methanol. The 
mixtures were incubated at 37°C for 30 min. Their absorbances were 
measured at 515 nm using spectrophotometer ultraviolet (UV)-Visible.
In vivo assay of antihyperuricemic and antioxidant activity [14]
A total of 36 of male Sprague Dawley rats were divided into six 
groups: Normal, negative (hyperuricemic) control, positive control 
(allopurinol), experimental groups given with low dose (140 mg/kg) of 
EBT (EBTL), experimental groups given with middle dose (280 mg/kg) 
of the extract (EBTM), and experimental groups given with high dose 
(560 mg/kg) of the extract (EBTH). Normal group was given standard 
lab diet, while other five groups were each given high-purine diet from 
chicken extract, 20 ml/kg body weight for 14 days. The extracts with 
referred dose were given 1 h after the daily meal. On the 14th day, 1 h after 
the main treatments, the rats were given potassium oxonate 250 mg/kg 
body weight, intraperitoneally. 3 h after the induction, all rats were 
anesthetized with ether, and the blood was collected, intracardially. 
Plasma was separated from blood cells by centrifugation at 3000 rpm 
for 10 min. Uric acid levels were measured by dichloro-hydroxybenzene 
sulfonate method using Biolabo kit and spectrophotometer (RD-60 
Semi-Auto Biochemistry) at 520 nm. Furthermore, malondialdehyde 
in the plasma was also measured using spectrophotometer UV-Visible.
Malondialdehyde (MDA) measurement [15]
About 200 ml plasma was added to 1.0 ml of trichloroacetate (TCA) 
(20%) and 2.0 ml of TBA (0.67%). The homogenized mixture was 
heated on water bath for 10 min. After cooling the room temperature, it 
was centrifuged at 3000 rpm for 10 min. The red filtrate’s absorbance 
was measured at 532 nm using spectrophotometer UV-Visible. 
Concentration of MDA was calculated from a standard curve prepared 
from known concentration at 0 to 1.6 nmol/µl.
RESULTS AND DISCUSSION
Phytochemical screening of EBT
Based on the Farnsworth method, EBT contained steroids, triterpenoids, 
alkaloids, flavonoids, quinones, and tannins. However, essential oils, 
coumarins, and saponins were not detected in EBT.
In vitro xanthine oxidase inhibitory activity and antioxidant 
activity from EBT
The extract yield obtained from the maceration process with ethanol 
70% was 17.2%. The result of the assay of the xanthine oxidase 
inhibitory activity was presented in Table 1. EBT at 600 ppm gave 
73.52% inhibition to the enzyme’s activity, while allopurinol gave 
73.74% inhibition only at 2 ppm concentration. The IC50 of EBT was 
447.86 ppm, while IC50 of allopurinol was 2.78 ppm.
The scavenging ability of DPPH free radical was used to analyze the 
antioxidant potential of EBT. The DPPH radical scavenging potential of the 
different EBT and Vitamin C (as positive control) is represented in Table 2. 
The IC50 of EBT was 14.05 µg/mL, while IC50 of Vitamin C was 2.71 µg/mL.
In addition, the antioxidant activity index (AAI) indicates the success 
of a compound in the effects of antioxidation. Đurđević et al. (2014) 
characterized compounds from its antioxidant activity as very 
strong (AAI >2), strong (AAI >1–2), moderate (AAI >0.5–1), and poor 
(AAI <0.5) [16]. Based on the criteria, EBT was categorized as a very 
strong antioxidant (AAI = 2.3623) as well as Vitamin C (AAI = 11.9809).
The experimental groups, fed with chicken essence (20 ml/kg) for 
14 days along with potassium oxonate on the 14th day, significantly 
have higher uric acid levels (6.93 mg/dL) than the normal group 
(4.41 mg/dL), p<0.05. After the extract administration for 14 days, the 
uric acid levels on day 14 from EBTL, EBTM, and EBTH (140 mg/kg BW, 


















EBT: Ethanol extract of Bawang Tiwai, SD: Standard deviation
Table 2: DPPH scavenging potential of EBT and Vitamin C
Sample Concentration 
(ppm)














EBT: Ethanol extract of bawang tiwai
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280 mg/kg BW, and 560 mg/kg BW) were 24 mg/dL, 5.16 mg/dL, and 
dan 4.9 mg/dL, respectively. Statistically, EBT at these three doses could 
inhibit the increase of uric acid level in rats compared to the negative 
group. On day 14, all experimental and allopurinol groups had similar 
uric acid level to the normal group (Fig. 1).
EBT could inhibit the increase of uric acid level in hyperuricemic rats as 
well as inhibit lipid peroxidation, proven by significant lower MDA level 
than negative groups.
This research showed that the hyperuricemic condition is occurred 
along with the increase of MDA level in plasma. The negative group has 
a significant higher MDA level in plasma (3.67±0.12 nmol/mL) than 
normal group (1.15±0.19 nmol/mL), p<0.05. MDA is the product of 
lipid peroxidation in the human body caused by the occurrence of free 
radicals (Liu et al.,). In many studies, the product of the peroxidation 
becomes the parameter to measure the oxidative stress (Alves et al., 
2010) [8]. High intake of dietary purine stimulates xanthine oxidase to 
catalyze the oxidation of purine into uric acid. The process produces 
reactive oxygen species that cause peroxidation of membrane lipid. 
EBTL, EBTM, and EBTH have capability to reduce the MDA level 
in plasma significantly. On day 14, the MDA levels of EBTL, EBTM, 
and EBTH were 2.16±0.61, 0.97±0.23, and 0.51±0.07 nmol/mL, 
respectively, while the MDA level of positive control (Vitamin C) was 
1.21±0.30 nmol/mL. Statistically, EBTM and Vitamin C have similar 
MDA level with the normal group.
DISCUSSION
According to the fact that each year the prevalence of gout 
and hyperuricemia increases rapidly, thus, we studied the EBT 
(E. palmifolia (L.) Merr) to investigate its potential to reduce the uric acid 
level in human body. In previous reports, flavonoid shows inhibition to 
xanthine oxidase activity. Cos et al., in his in vitro study, approved that 
isorhamnetin, baicalein, kaempferol, and morin had inhibition to the 
enzyme’s activity with IC50 2.51, 2.79, 1.06, and 10.1 µM, respectively [5]. 
While Mo et al. performed in vivo assays of flavonoid including quercetin, 
morin, myricetin, kaempferol, and puerarin which significantly reduced 
the uric acid level in mice 26.94%, 28.99%, 30.59%, 35.39%, and 31.28%, 
respectively [6]. Bulbous plants are cultivars that contain flavonoid, 
especially kaempferol and quercetin. We hypothesized that bawang 
tiwai possess these flavonoids as the other bulbous plants. Moreover, the 
flavonoids content of bawang tiwai has not been empirically reported. 
The amount of quercetine in bawang tiwai was still unknown. Thus, we 
suggest a further research investigating the qualitative and quantitative 
study of flavonoids contained in bawang tiwai.
Apaya and Chichioco-Hern (2011) in the previous report categorized 
extract as strong inhibitor if it inhibits more than 50% of the enzyme’s 
activity at 50 ppm concentration [17]. Based on the results of the 
in vitro assay, EBT has low inhibition to xanthine oxidase activity. For 
50% inhibition, EBT required 44,786 ppm concentration. However, 
the in vivo assay provides expected result. Statistically, EBT in all 
doses (140, 280, and 560 mg/kg body weight) has significant lower 
uric acid level than the negative control. EBT has capability to reduce 
the uric acid level in hyperuricemic rats. The incoherent results 
of in vitro and in vivo assays are probably occurred because the 
antihyperuricemic activity of EBT was based on different mechanism 
than inhibition of xanthine oxidase. In future research, the uricosuric 
and uricostatic of EBT could be explored that it could contribute to 
reduce the uric acid level.
Based on the results, it is important to consume antioxidant as well 
as antihyperuricemic compounds to suppress the symptoms gout 
and hyperuricemia. Bawang tiwai has both antihyperuricemic and 
antioxidant activities; therefore, it could be further investigated as 
alternative herbs to overcome hyperuricemia.
CONCLUSION
The ethanol extracts of bawang tiwai (E. palmifolia (L.) Merr) were 
potential to reduce uric acid level at 140, 280, and 560 mg/kg body 
weight, but possibly without inhibition against xanthine oxydase 
activity. All doses of ethanol extracts of bawang tiwai could inhibit lipid 
peroxidation in hyperuricemic condition caused by a high purine diet in 
14 days. Thus, we conclude that EBT had antihyperuricemic as well as 
antioxidant activities.
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